Cargando…

Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice

BACKGROUND: A growing number of rapid Helicobacter pylori antibody tests are commercially available now, however, some of these tests are often used without sufficient evaluation. The aim of this study was to evaluate the performance of a commercially available rapid whole-blood immunoassay (gabCont...

Descripción completa

Detalles Bibliográficos
Autores principales: Enko, Dietmar, Halwachs-Baumann, Gabriele, Stolba, Robert, Rössler, Ortrun, Kriegshäuser, Gernot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977652/
https://www.ncbi.nlm.nih.gov/pubmed/27503600
http://dx.doi.org/10.1186/s12941-016-0161-1
_version_ 1782447069354524672
author Enko, Dietmar
Halwachs-Baumann, Gabriele
Stolba, Robert
Rössler, Ortrun
Kriegshäuser, Gernot
author_facet Enko, Dietmar
Halwachs-Baumann, Gabriele
Stolba, Robert
Rössler, Ortrun
Kriegshäuser, Gernot
author_sort Enko, Dietmar
collection PubMed
description BACKGROUND: A growing number of rapid Helicobacter pylori antibody tests are commercially available now, however, some of these tests are often used without sufficient evaluation. The aim of this study was to evaluate the performance of a commercially available rapid whole-blood immunoassay (gabControl(®)H. pylori; gabmed GmbH, Köln, Germany), for the qualitative detection of IgG antibodies against H. pylori with the (13)C-urea breath test ((13)C-UBT) serving as a reference method. METHODS: A total of 108 consecutive outpatients, who were referred for (13)C-UBT by general practitioners and specialists, were also tested for H. pylori infection by the gabControl(®)H. pylori immunoassay. The clinical performance of this rapid whole-blood test was evaluated by determining the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) compared to the (13)C-UBT. The agreement between the two tests was calculated using Cohen’s Kappa (κ) with 95 % confidence intervals (CI). RESULTS: The agreement between the gabControl(®)H. pylori assay and the (13)C-UBT was 0.62 [95 % confidence intervals (CIs) 0.47–0.76; P < 0.001]. With the (13)C-UBT serving as the non-invasive gold standard method of H. pylori diagnosis, the gabControl(®)H. pylori assay demonstrated a sensitivity and specificity of 91.4 and 76.7 %, respectively, with a PPV of 65.3 % and a NPV of 94.9 %. Seventeen (15.7 %) individuals with a positive H. pylori anamnesis showed a negative (13)C-UBT and were typed positive by the gabControl(®)H. pylori assay. Of these, 13 (76.5 %) and 3 individuals (17.6 %) had completed one and two eradication therapies, respectively. CONCLUSIONS: The gabControl(®)H. pylori immunoassay is a rapid and easy to use first line screening tool for H. pylori IgG antibody detection in daily clinical practice. However, this assay should not be used for confirmation of the successful H. pylori eradication after antibiotic treatment.
format Online
Article
Text
id pubmed-4977652
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49776522016-08-10 Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice Enko, Dietmar Halwachs-Baumann, Gabriele Stolba, Robert Rössler, Ortrun Kriegshäuser, Gernot Ann Clin Microbiol Antimicrob Research BACKGROUND: A growing number of rapid Helicobacter pylori antibody tests are commercially available now, however, some of these tests are often used without sufficient evaluation. The aim of this study was to evaluate the performance of a commercially available rapid whole-blood immunoassay (gabControl(®)H. pylori; gabmed GmbH, Köln, Germany), for the qualitative detection of IgG antibodies against H. pylori with the (13)C-urea breath test ((13)C-UBT) serving as a reference method. METHODS: A total of 108 consecutive outpatients, who were referred for (13)C-UBT by general practitioners and specialists, were also tested for H. pylori infection by the gabControl(®)H. pylori immunoassay. The clinical performance of this rapid whole-blood test was evaluated by determining the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) compared to the (13)C-UBT. The agreement between the two tests was calculated using Cohen’s Kappa (κ) with 95 % confidence intervals (CI). RESULTS: The agreement between the gabControl(®)H. pylori assay and the (13)C-UBT was 0.62 [95 % confidence intervals (CIs) 0.47–0.76; P < 0.001]. With the (13)C-UBT serving as the non-invasive gold standard method of H. pylori diagnosis, the gabControl(®)H. pylori assay demonstrated a sensitivity and specificity of 91.4 and 76.7 %, respectively, with a PPV of 65.3 % and a NPV of 94.9 %. Seventeen (15.7 %) individuals with a positive H. pylori anamnesis showed a negative (13)C-UBT and were typed positive by the gabControl(®)H. pylori assay. Of these, 13 (76.5 %) and 3 individuals (17.6 %) had completed one and two eradication therapies, respectively. CONCLUSIONS: The gabControl(®)H. pylori immunoassay is a rapid and easy to use first line screening tool for H. pylori IgG antibody detection in daily clinical practice. However, this assay should not be used for confirmation of the successful H. pylori eradication after antibiotic treatment. BioMed Central 2016-08-08 /pmc/articles/PMC4977652/ /pubmed/27503600 http://dx.doi.org/10.1186/s12941-016-0161-1 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Enko, Dietmar
Halwachs-Baumann, Gabriele
Stolba, Robert
Rössler, Ortrun
Kriegshäuser, Gernot
Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice
title Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice
title_full Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice
title_fullStr Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice
title_full_unstemmed Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice
title_short Performance evaluation of a rapid whole-blood immunoassay for the detection of IgG antibodies against Helicobacter pylori in daily clinical practice
title_sort performance evaluation of a rapid whole-blood immunoassay for the detection of igg antibodies against helicobacter pylori in daily clinical practice
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977652/
https://www.ncbi.nlm.nih.gov/pubmed/27503600
http://dx.doi.org/10.1186/s12941-016-0161-1
work_keys_str_mv AT enkodietmar performanceevaluationofarapidwholebloodimmunoassayforthedetectionofiggantibodiesagainsthelicobacterpyloriindailyclinicalpractice
AT halwachsbaumanngabriele performanceevaluationofarapidwholebloodimmunoassayforthedetectionofiggantibodiesagainsthelicobacterpyloriindailyclinicalpractice
AT stolbarobert performanceevaluationofarapidwholebloodimmunoassayforthedetectionofiggantibodiesagainsthelicobacterpyloriindailyclinicalpractice
AT rosslerortrun performanceevaluationofarapidwholebloodimmunoassayforthedetectionofiggantibodiesagainsthelicobacterpyloriindailyclinicalpractice
AT kriegshausergernot performanceevaluationofarapidwholebloodimmunoassayforthedetectionofiggantibodiesagainsthelicobacterpyloriindailyclinicalpractice